Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — March 2026

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Mar 4, 2026
Sale
Shares
212
Price
$514.86
Total Value
$109.15K
Shares Held After
124,162
% of Holdings
0.2%
Mar 4, 2026
Sale
Shares
815
Price
$513.63
Total Value
$418.61K
Shares Held After
124,374
% of Holdings
0.7%
Mar 4, 2026
Sale
Shares
1,241
Price
$512.92
Total Value
$636.53K
Shares Held After
125,189
% of Holdings
1.0%
Mar 4, 2026
Sale
Shares
1,370
Price
$511.80
Total Value
$701.17K
Shares Held After
126,430
% of Holdings
1.1%
Mar 4, 2026
Sale
Shares
678
Price
$510.71
Total Value
$346.26K
Shares Held After
127,800
% of Holdings
0.5%
Mar 4, 2026
Sale
Shares
447
Price
$509.89
Total Value
$227.92K
Shares Held After
128,478
% of Holdings
0.3%

Tectonic Therapeutic, Inc. (TECX)

McNamara Peter — Chief Scientific Officer
Mar 4, 2026
Sale
Shares
1,650
Price
$25.00
Total Value
$41.25K
Shares Held After
58,832
% of Holdings
2.7%
Mar 4, 2026
Sale
Shares
175,000
Price
$2.17
Total Value
$379.75K
Shares Held After
1,998,584
% of Holdings
8.1%

NovoCure Limited (NVCR)

Leupin Nicolas — Former Chief Medical Officer
Mar 4, 2026
Sale
Shares
1,100
Price
$13.31
Total Value
$14.64K
Shares Held After
102,979
% of Holdings
1.1%
Mar 4, 2026
Sale
Shares
40
Price
$497.05
Total Value
$19.88K
Shares Held After
130
% of Holdings
23.5%
Mar 4, 2026
Sale
Shares
480
Price
$495.78
Total Value
$237.98K
Shares Held After
170
% of Holdings
73.8%
Mar 4, 2026
Sale
Shares
215
Price
$494.74
Total Value
$106.37K
Shares Held After
650
% of Holdings
24.9%
Mar 4, 2026
Sale
Shares
185
Price
$493.40
Total Value
$91.28K
Shares Held After
865
% of Holdings
17.6%
Mar 4, 2026
Sale
Shares
243
Price
$492.44
Total Value
$119.66K
Shares Held After
1,050
% of Holdings
18.8%
Mar 4, 2026
Sale
Shares
485
Price
$491.33
Total Value
$238.30K
Shares Held After
1,293
% of Holdings
27.3%
Mar 4, 2026
Sale
Shares
1,808
Price
$490.52
Total Value
$886.86K
Shares Held After
1,778
% of Holdings
50.4%
Mar 4, 2026
Sale
Shares
2,290
Price
$489.68
Total Value
$1.12M
Shares Held After
3,586
% of Holdings
39.0%
Mar 4, 2026
Sale
Shares
2,429
Price
$488.63
Total Value
$1.19M
Shares Held After
5,876
% of Holdings
29.2%
Mar 4, 2026
Sale
Shares
926
Price
$487.55
Total Value
$451.47K
Shares Held After
8,305
% of Holdings
10.0%
Mar 4, 2026
Sale
Shares
399
Price
$486.42
Total Value
$194.08K
Shares Held After
9,231
% of Holdings
4.1%

NovoCure Limited (NVCR)

Brackmann Christoph — Chief Financial Officer
Mar 4, 2026
Sale
Shares
6,412
Price
$13.31
Total Value
$85.31K
Shares Held After
182,842
% of Holdings
3.4%

Guardant Health, Inc. (GH)

Kalia Kumud — Chief Information Officer
Mar 4, 2026
Sale
Shares
13,020
Price
$95.73
Total Value
$1.25M
Shares Held After
37,643
% of Holdings
25.7%

Guardant Health, Inc. (GH)

Kalia Kumud — Chief Information Officer
Mar 4, 2026
Sale
Shares
26,980
Price
$95.12
Total Value
$2.57M
Shares Held After
50,663
% of Holdings
34.7%

EyePoint, Inc. (EYPT)

Ribeiro Ramiro — Chief Medical Officer
Mar 4, 2026
Sale
Shares
2,438
Price
$17.87
Total Value
$43.57K
Shares Held After
0
% of Holdings
100.0%

NovoCure Limited (NVCR)

Leonard Frank X — Chief Executive Officer
Mar 4, 2026
Sale
Shares
5,607
Price
$13.31
Total Value
$74.60K
Shares Held After
493,793
% of Holdings
1.1%

NovoCure Limited (NVCR)

Puri Michal Nath — Chief Human Resources Officer
Mar 4, 2026
Sale
Shares
1,100
Price
$13.31
Total Value
$14.64K
Shares Held After
201,322
% of Holdings
0.5%

Orthofix Medical Inc. (OFIX)

McPherron Aviva — Pres, Global Ops & Qual
Mar 4, 2026
Sale
Shares
1,296
Price
$12.92
Total Value
$16.74K
Shares Held After
69,116
% of Holdings
1.8%

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Savage Brian — Interim Chief Legal Officer
Mar 4, 2026
Sale
Shares
1,186
Price
$32.46
Total Value
$38.50K
Shares Held After
8,461
% of Holdings
12.3%

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Savage Brian — Interim Chief Legal Officer
Mar 4, 2026
Sale
Shares
1,489
Price
$32.46
Total Value
$48.34K
Shares Held After
6,181
% of Holdings
19.4%

Zai Lab Ltd (ZLAB)

Du Ying — Director
Mar 4, 2026
Sale
Shares
35,710
Price
$19.32
Total Value
$689.83K
Shares Held After
964,161
% of Holdings
3.6%

Zai Lab Ltd (ZLAB)

Du Ying — Director
Mar 4, 2026
Sale
Shares
14,290
Price
$18.78
Total Value
$268.32K
Shares Held After
999,871
% of Holdings
1.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Mar 4, 2026
Sale
Shares
57
Price
$325.67
Total Value
$18.56K
Shares Held After
21,227
% of Holdings
0.3%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Mar 4, 2026
Sale
Shares
75
Price
$324.88
Total Value
$24.37K
Shares Held After
21,284
% of Holdings
0.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Mar 4, 2026
Sale
Shares
210
Price
$323.84
Total Value
$68.01K
Shares Held After
21,359
% of Holdings
1.0%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Mar 4, 2026
Sale
Shares
96
Price
$323.01
Total Value
$31.01K
Shares Held After
21,569
% of Holdings
0.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Mar 4, 2026
Sale
Shares
79
Price
$321.82
Total Value
$25.42K
Shares Held After
21,665
% of Holdings
0.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Mar 4, 2026
Sale
Shares
59
Price
$320.81
Total Value
$18.93K
Shares Held After
21,744
% of Holdings
0.3%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Mar 4, 2026
Sale
Shares
28
Price
$320.01
Total Value
$8.96K
Shares Held After
21,803
% of Holdings
0.1%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Mar 4, 2026
Sale
Shares
29
Price
$319.03
Total Value
$9.25K
Shares Held After
21,831
% of Holdings
0.1%

uniQure N.V. (QURE)

KLEMT CHRISTIAN — Chief Financial Officer
Mar 4, 2026
Sale
Shares
12,000
Price
$9.06
Total Value
$108.72K
Shares Held After
226,581
% of Holdings
5.0%

RHYTHM PHARMACEUTICALS, INC. (RYTM)

German Christopher Paul — Corporate Controller & CAO
Mar 4, 2026
Sale
Shares
5,614
Price
$89.56
Total Value
$502.79K
Shares Held After
160
% of Holdings
97.2%
Mar 4, 2026
Sale
Shares
3,571
Price
$146.82
Total Value
$524.29K
Shares Held After
12,134
% of Holdings
22.7%

PepGen Inc. (PEPG)

McArthur James G — Director
Mar 4, 2026
Sale
Shares
131
Price
$6.33
Total Value
$828.58
Shares Held After
296,326
% of Holdings
0.0%

PepGen Inc. (PEPG)

McArthur James G — Director
Mar 4, 2026
Sale
Shares
5,144
Price
$6.23
Total Value
$32.05K
Shares Held After
296,457
% of Holdings
1.7%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

McKechnie Duncan — EVP, Chief Commercial Officer
Mar 4, 2026
Sale
Shares
2,437
Price
$475.30
Total Value
$1.16M
Shares Held After
15,122
% of Holdings
13.9%

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Daniell Richard — EVP, Europe Commercial
Mar 4, 2026
Sale
Shares
37,372
Price
$32.95
Total Value
$1.23M
Shares Held After
85,755
% of Holdings
30.4%

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Daniell Richard — EVP, Europe Commercial
Mar 4, 2026
Sale
Shares
20,461
Price
$32.46
Total Value
$664.26K
Shares Held After
123,127
% of Holdings
14.2%

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Daniell Richard — EVP, Europe Commercial
Mar 4, 2026
Sale
Shares
33,512
Price
$32.46
Total Value
$1.09M
Shares Held After
123,127
% of Holdings
21.4%

PepGen Inc. (PEPG)

Donnelly Noel — Chief Financial Officer
Mar 4, 2026
Sale
Shares
52
Price
$6.33
Total Value
$328.90
Shares Held After
111,603
% of Holdings
0.0%

PepGen Inc. (PEPG)

Donnelly Noel — Chief Financial Officer
Mar 4, 2026
Sale
Shares
2,032
Price
$6.23
Total Value
$12.66K
Shares Held After
111,655
% of Holdings
1.8%
Version: v26.3.33